Pinnacle Financial Partners (Tennessee)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20.9M | Sell |
43,163
-115
| -0.3% | -$53.5K | 0.5% | 54 |
|
|
2025
Q2 | $17.5M | Sell |
43,278
-13,592
| -24% | -$5.68M | 0.37% | 73 |
|
|
2025
Q1 | $28.5M | Sell |
56,870
-20
| -0% | -$10.8K | 0.58% | 39 |
|
|
2024
Q4 | $30.7M | Sell |
56,890
-49
| -0.1% | -$26.9K | 0.62% | 31 |
|
|
2024
Q3 | $35.2M | Buy |
56,939
+51
| +0.1% | +$30.2K | 0.71% | 26 |
|
|
2024
Q2 | $31.8M | Sell |
56,888
-27
| -0% | -$15.5K | 0.68% | 29 |
|
|
2024
Q1 | $33.1M | Buy |
56,915
+569
| +1% | +$319K | 0.72% | 26 |
|
|
2023
Q4 | $29.9M | Sell |
56,346
-285
| -0.5% | -$138K | 0.71% | 24 |
|
|
2023
Q3 | $28.7M | Sell |
56,631
-587
| -1% | -$313K | 0.74% | 29 |
|
|
2023
Q2 | $29.9M | Buy |
57,218
+92
| +0.2% | +$49.6K | 0.75% | 27 |
|
|
2023
Q1 | $32.9M | Buy |
57,126
+784
| +1% | +$442K | 0.88% | 23 |
|
|
2022
Q4 | $31M | Buy |
56,342
+633
| +1% | +$335K | 0.9% | 25 |
|
|
2022
Q3 | $28.3M | Buy |
55,709
+329
| +0.6% | +$184K | 1.02% | 23 |
|
|
2022
Q2 | $30.1M | Sell |
55,380
-200
| -0.4% | -$110K | 1.07% | 19 |
|
|
2022
Q1 | $32.8M | Sell |
55,580
-347
| -0.6% | -$199K | 1.04% | 19 |
|
|
2021
Q4 | $37.3M | Buy |
55,927
+5,125
| +10% | +$3.2M | 1.16% | 15 |
|
|
2021
Q3 | $29M | Buy |
50,802
+40,244
| +381% | +$22.1M | 1.02% | 19 |
|
|
2021
Q2 | $5.33M | Buy |
10,558
+5,494
| +108% | +$2.59M | 0.22% | 118 |
|
|
2021
Q1 | $2.31M | Buy |
5,064
+66
| +1% | +$31.5K | 0.1% | 155 |
|
|
2020
Q4 | $2.33M | Sell |
4,998
-96
| -2% | -$45K | 0.11% | 152 |
|
|
2020
Q3 | $2.25M | Sell |
5,094
-179
| -3% | -$74K | 0.12% | 144 |
|
|
2020
Q2 | $1.91M | Buy |
5,273
+83
| +2% | +$27.8K | 0.11% | 158 |
|
|
2020
Q1 | $1.47M | Buy |
5,190
+92
| +2% | +$29K | 0.1% | 166 |
|
|
2019
Q4 | $1.66M | Buy |
5,098
+60
| +1% | +$18.2K | 0.1% | 167 |
|
|
2019
Q3 | $1.47M | Buy |
5,038
+339
| +7% | +$97.1K | 0.11% | 168 |
|
|
2019
Q2 | $1.38M | Buy |
4,699
+12
| +0.3% | +$3.31K | 0.1% | 171 |
|
|
2019
Q1 | $1.28M | Buy |
4,687
+609
| +15% | +$152K | 0.1% | 169 |
|
|
2018
Q4 | $912K | Buy |
4,078
+1,271
| +45% | +$298K | 0.09% | 181 |
|
|
2018
Q3 | $685K | Buy |
2,807
+21
| +0.8% | +$4.83K | 0.06% | 212 |
|
|
2018
Q2 | $578K | Buy |
2,786
+263
| +10% | +$55.8K | 0.05% | 217 |
|
|
2018
Q1 | $521K | Buy |
2,523
+1,009
| +67% | +$212K | 0.05% | 213 |
|
|
2017
Q4 | $287K | Buy |
+1,514
| New | +$290K | 0.03% | 264 |
|
|
2017
Q3 | – | Sell |
-410
| Closed | -$72K | – | 431 |
|
|
2017
Q2 | $72K | Buy |
+410
| New | +$68.9K | 0.01% | 319 |
|
|
2013
Q4 | – | Sell |
-200
| Closed | -$18K | – | 200 |
|
|
2013
Q3 | $18K | Hold |
200
| – | – | 0.01% | 138 |
|
|
2013
Q2 | $17K | Buy |
+200
| New | +$16.6K | 0.01% | 132 |
|
Other funds holding TMO
Pinnacle Financial Partners (Tennessee)'s TMO Position: Q3 2025 in Review
Pinnacle Financial Partners (Tennessee) reduced its Thermo Fisher Scientific (TMO) stake by 0.27% in Q3 2025, selling an estimated $53.5K and leaving 43,163 shares worth $20.9M. The position accounts for 0.5% of the portfolio, ranked #54.
Pinnacle Financial Partners (Tennessee) first reported a position in TMO in Q2 2013 and has held it in 35 quarters since. The position peaked at $37.3M in Q4 2021. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Pinnacle Financial Partners (Tennessee) held 43,163 shares of Thermo Fisher Scientific worth $20.9M as of Q3 2025.
- Pinnacle Financial Partners (Tennessee) sold 115 Thermo Fisher Scientific shares in Q3 2025, an estimated $53.5K.
- Thermo Fisher Scientific made up 0.5% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #54 holding.
- Pinnacle Financial Partners (Tennessee) first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 35 quarters since.
- Pinnacle Financial Partners (Tennessee)'s Thermo Fisher Scientific position peaked at $37.3M in Q4 2021.
- 2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.